Use carefully with peptides: Retinol/Retinoids: These can work together but introduce slowly
Low-dose naltrexone (LDN) is an emerging therapy being studied for Hashimotos due to its immune-modulating properties
By preventing oxidative damage, it helps maintain skin health, addressing issues such as fine lines, wrinkles, and sagging
It mimics ghrelin signaling at the pituitary, triggering sustained growth hormone release
Unlike non-selective secretagogues, Ipamorelin exhibits a high degree of specificity, significantly reducing the risk of stimulating other pituitary hormones such as prolactin or cortisol
Cagrilintide monotherapy for treatment of obesity In a 26-week phase 2 trial (n=706, 62 Percentage women, mean age 52 years), cagrilintide was evaluated in 5 groups of subjects receiving 0.3, 0.6, 1.2, 2.4, and 4.5 mg/week as treatment for obesity in comparison with liraglutide 3.0 mg/day, and placebo (table 1) [9]